An Open-Label Study of the Pharmacokinetics and Safety of MNK-155 (7.5 mg in Postsurgical Adolescent Subjects (Ages 12 to 17) With Moderate to Severe Acute Pain
Clinical Trial Grant
Administered By
Anesthesiology, Pediatrics
Awarded By
Mallinckrodt Pharmaceuticals
Start Date
October 1, 2015
End Date
September 30, 2016
Administered By
Anesthesiology, Pediatrics
Awarded By
Mallinckrodt Pharmaceuticals
Start Date
October 1, 2015
End Date
September 30, 2016